Navigation Links
Tabers Cyclopedic Medical Dictionary 20th edition

ProductsTabers Cyclopedic Medical Dictionary 20th edition
Company Medical Wizards™
Item Tabers Cyclopedic Medical Dictionary 20th edition
Features 
  • 56,000 definitions
  • More than 6,000 updated terms
  • Almost 100 Patient Care sections and reference materials
  • Nearly 700 color images and illustrations
  • Improved placement of multi-word entries in natural word order
  • Cautions statements have been added to almost 350 terms
  • Updated and expanded appendices
  • Approximately 30,000 pronunciations
  • Cross-linking between terms
Description Tabers Cyclopedic Medical Dictionary 20th edition was developed by Medical Wizards and based on F.A. Daviss book, and is now available on PDA. It defines over 56,000 entries. Enhanced for nurses and health-care professionals, patients and the general public - to better understand diseases and health-care terminology.
Info Medical Wizards™
Customer Service: 888.633.9449
Web site: http://www.medicalwizards.com/client/newhome.aspx

Related medicine products :

1. Tabers Cyclopedic Medical Dictionary, 20th Ed.
2. Tabers Cyclopedic Medical Dictionary
3. Disposable Medical Penlight
4. MaximEyes Practice Management and Electronic Medical Records Software Solutions
5. Sony LMD-181MD Medical Grade LCD
6. Sony LMD-151MD Medical Grade LCD
7. Sony PVM-20M2MDU Medical Grade Monitor
8. Sony PVM-14M2MDU Medical Grade Monitor
9. PRAXIS® Electronic Medical Records v. 2.19
10. TTI Medical Digital Video Disk Recorder
11. TTI Medical Medicap Still Image Capture
A general purpose instrument for use around the femur and acetabulum.
Delicate side cutting wire cutter with carbide inserts.
The osteotome shafts are manufactured with stainless steel and are available both straight and curved in 1/4" and 1/2" sizes.
... special purpose scintimammography camera. Offeri...the edge of the detector and separate the breast f...and stabilization and stereotactic imaging for bio...era is a dedicated system with breast containment ...
Medicine Products:
(Date:12/3/2008)...., Dec. 3 MedQuist Inc. (Nasdaq: ... Organization (MTSO) in the world, is pleased to a...l legal matters , , Resolution of the DOJ ... the Company received an administrative HIPAA subp...nt of Justice ("DOJ") on December 17, 2004. The su...
(Date:12/3/2008)...aggressive surgeries were free of tumor recurrence... ROCHESTER, Minn., Dec. 3 /PRNewswire-USNewswire/...th low-grade gliomas survived longest when they un...e the entire tumor. If safely removing the entire ...antly longer when surgery was followed by radiatio...
(Date:12/3/2008)... Aurora Health Care,s Women,s Pavi... and Body Solutions Salon and Spa of,New Berlin p...or breast,cancer; pink hair extensions. , ...ons were being sold for,$15 each at the Aurora Wo...,Solutions Salon and Spa in New Berlin. The profit...
(Date:12/3/2008)...PRNewswire/ -- Breast-Specific Gamma Imaging (BSGI...ty than breast MRI in patients with,inconclusive ...iagnosis of,breast cancer, according to findings ...ological Society of North America (RSNA). BSGI is ...djunctive tool to mammography that can identify,l...
Breaking Medicine News(10 mins):Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 5Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 6Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2
...The burden of dementia in developing countries is ...s trying to help carers to cope. As the world popu... disease - including dementia. It is hard enough c...tion has been common for many years. Imagine tryin...
...Obesity is a disease and a growing health threat ...upropion can help overweight and obese women lose ...h blood pressure, diabetes, cancer and heart disea...in the long term, and there has seen to be a need,...
...Scientists warn that, too much sleep and snoring c...can researchers from the University of Buffalo, Ne...ours a night, snoring or being drowsy during the d... this means snoring and sleep disorders will now h...
...Men who are regularly exposed to moderate to high ... having a low sperm count, according to a study pu... Environmental Medicine. Professional printers, a...at highest risk. The only factor common to all of ...
Other Medicine News:
(Date:12/1/2008)... Genaera Corporation (N...jects has begun in study MSI-1436C-102 (Study 102)...odusquemine (MSI-1436) in overweight and obese typ... the treatment of type 2 diabetes and obesity whic...ulin and leptin pathways through the highly select...
(Date:12/1/2008)...irstCall/ -- GeoVax Labs, Inc.,(OTC Bulletin Boar...eveloping,human vaccines for diseases caused by H...ectious agents, announced today that the launch of...e in twelve sites across North and South America.,...The National Institutes of,Health (NIH), and the ...
(Date:11/30/2008)...SNewswire/ -- Abnormalities in auditory and langua...tism spectrum disorder by using magnetoencephalogr...t the annual meeting of the Radiological Society o...can record the tiny magnetic fields associated wit..., Ph.D., vice chair of research in the Department ...
(Date:11/27/2008)...of acute lymphoblastic leukemia relapse cases aris...osis , , MEMPHIS, Tenn., Nov. 27 /PRNewswir... Research Hospital have identified distinctive gen...acute lymphoblastic leukemia (ALL) that cause rela...atments for ALL relapse in children and, ultimatel...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 1Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 2Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 3Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill Rom 10th Annual Pressure Ulcer Survey 647 4MedQuist Re launches New Improved Web Site 642 1MedQuist Re launches New Improved Web Site 642 2NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 1NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 2NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 3NPS Pharmaceuticals Commences Tender Offer for 3 0 25 Convertible Notes Due 2008 409 4Proteon Therapeutics Completes 2412 Million Financing and Hires CFO 404 1Proteon Therapeutics Completes 2412 Million Financing and Hires CFO 404 2
...egistration Program to Begin Third Quarter 2007, H...l/ -- Kosan,Biosciences Incorporated presented dat...f its lead Hsp90 inhibitor, tanespimycin,(KOS-953)...ing a,high degree of antitumor activity and tolera...reviously progressed following treatment,with mult...
...BUSINESS WIRE)--Jun 4, 2007 - Molecular Insight,Ph... that the,company will present the results of seve... of the Society of Nuclear Medicine (SNM) in,Washi...ra(TM),(Ultratrace (131)I-MIBG), the company,s cli...or the treatment of malignant,neuroendocrine tumor...
Other Medicine Technology:Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 2Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 3Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 4Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 5Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 6Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 4